Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Calcium voltage-gated channel auxiliary subunit beta 2 (CACNB2) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the CACNB2 transcript that governs the expression of the Cavbeta2 protein. This protein is an essential auxiliary subunit of L-type voltage-gated calcium channels, responsible for modulating channel trafficking to the plasma membrane and adjusting their biophysical gating properties (UniProt: Q06945). The 3'-UTR serves as a primary site for post-transcriptional regulation, containing binding sequences for various microRNAs, such as miR-153 and miR-206, which can suppress translation or promote mRNA decay (PubMed: 20639540). Dysregulation of this region or mutations within the CACNB2 gene are strongly associated with cardiac channelopathies like Brugada syndrome and early repolarization syndrome, as well as complex neuropsychiatric disorders including schizophrenia and bipolar disorder (PubMed: 17224476, 21852963). From a therapeutic perspective, the CACNB2 mRNA 3'-UTR is a target for RNA-based interventions, such as antisense oligonucleotides (ASOs) or microRNA mimics, designed to fine-tune calcium channel density in excitable tissues. By targeting the mRNA rather than the protein, researchers aim to achieve high specificity in modulating calcium signaling to treat arrhythmias or hypertension. Current development focuses on improving the stability and delivery of these RNA-targeted agents to the heart and central nervous system (PubMed: 25650107).
The target is modulated via antisense inhibition or RNA interference, where synthetic oligonucleotides or microRNA mimics bind to the 3'-UTR to induce mRNA degradation or block translation, thereby reducing the density of functional calcium channels on the cell membrane (PubMed: 20639540, 25650107).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium voltage-gated channel auxiliary subunit beta 2 mRNA 3'-untranslated region (CACNB2 mRNA 3'-UTR).